HeyJaredIBD Technology
IBD Technology is a market-focused news outlet centered on technology-driven business and investing coverage, drawing heavily from the editorial approach of Investor’s Business Daily.
- Indexed articles, last 90 days
- 50
- Latest publication
- Aug 3, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 23, 2026
Latest articles
Nvidia Stock Retakes Key Level As Chip Stocks Waver (opens the original)
Read excerpt
Chip stocks were a mixed bag on Monday. However, Nvidia stock retook a key support level. The post Nvidia Stock Retakes Key Level As Chip Stocks Waver appeared first on Investor's Business Daily.
Microsoft Stock Breaks Out Into Buy Zone. Here's Why. (opens the original)
Read excerpt
Microsoft stock broke out of a cup base on Monday following its beat-and-raise earnings report last week. The post Microsoft Stock Breaks Out Into Buy Zone. Here's Why. appeared first on Investor's Business Daily.
Amazon Stock Hits $3 Trillion Market Cap As AI Cloud Hyperscalers Rally (opens the original)
Read excerpt
Amazon stock soared Monday as investors digested a strong Q2 earnings season for cloud hyperscalers AWS, Google and Microsoft. The post Amazon Stock Hits $3 Trillion Market Cap As AI Cloud Hyperscalers Rally appeared first on Investor's Business Daily.
Three Noteworthy Biotechs Just Reported Earnings — And Only One Recovered (opens the original)
Read excerpt
Top-notch biotech stocks TG Therapeutics and Twist Bioscience diverged Monday on mixed earnings reports. The post Three Noteworthy Biotechs Just Reported Earnings — And Only One Recovered appeared first on Investor's Business Daily.
AstraZeneca Nosedives On A Rumored Megamerger; Is $160 Billion Enough? (opens the original)
Read excerpt
AstraZeneca stock took a nosedive Monday amid reports it's mulling a megamerger with Bristol Myers Squibb. The post AstraZeneca Nosedives On A Rumored Megamerger; Is $160 Billion Enough? appeared first on Investor's Business Daily.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.